Alpha DNA Investment Management LLC Buys New Stake in Genpact Limited (NYSE:G)

Alpha DNA Investment Management LLC acquired a new position in Genpact Limited (NYSE:G - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 9,756 shares of the business services provider's stock, valued at approximately $419,000.

Several other large investors also recently added to or reduced their stakes in G. Stifel Financial Corp purchased a new stake in Genpact in the 3rd quarter worth approximately $1,197,000. Blue Trust Inc. lifted its position in shares of Genpact by 8.7% in the fourth quarter. Blue Trust Inc. now owns 5,531 shares of the business services provider's stock valued at $217,000 after acquiring an additional 441 shares in the last quarter. Burney Co. lifted its position in shares of Genpact by 242.8% in the fourth quarter. Burney Co. now owns 130,798 shares of the business services provider's stock valued at $5,618,000 after acquiring an additional 92,641 shares in the last quarter. KBC Group NV bought a new position in shares of Genpact in the fourth quarter worth about $298,000. Finally, JPMorgan Chase & Co. grew its position in shares of Genpact by 192.8% during the third quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider's stock worth $122,701,000 after purchasing an additional 2,060,595 shares in the last quarter. 96.03% of the stock is currently owned by institutional investors.

Insider Activity

In other news, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the transaction, the chief executive officer now directly owns 310,246 shares in the company, valued at approximately $15,167,926.94. This trade represents a 4.20 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 2.80% of the company's stock.

Genpact Trading Up 0.5 %

Shares of NYSE:G traded up $0.26 during trading on Thursday, reaching $47.81. 300,915 shares of the company were exchanged, compared to its average volume of 1,467,246. The business's fifty day simple moving average is $50.04 and its 200-day simple moving average is $46.20. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85. Genpact Limited has a 12-month low of $30.38 and a 12-month high of $56.76. The firm has a market capitalization of $8.40 billion, a PE ratio of 16.84, a P/E/G ratio of 1.84 and a beta of 1.06.

Genpact (NYSE:G - Get Free Report) last issued its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. On average, research analysts anticipate that Genpact Limited will post 3.21 EPS for the current year.

Genpact Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th were given a dividend of $0.17 per share. This is an increase from Genpact's previous quarterly dividend of $0.15. The ex-dividend date was Tuesday, March 11th. This represents a $0.68 dividend on an annualized basis and a yield of 1.42%. Genpact's dividend payout ratio (DPR) is 23.94%.

Analyst Upgrades and Downgrades

G has been the subject of several research reports. Mizuho increased their price objective on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Needham & Company LLC raised their price target on Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a report on Friday, February 7th. Jefferies Financial Group raised Genpact from a "hold" rating to a "buy" rating and upped their price objective for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Finally, TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and raised their target price for the company from $45.00 to $60.00 in a report on Friday, February 7th. Five research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat.com, Genpact currently has an average rating of "Hold" and a consensus target price of $50.38.

Genpact Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.